Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;12(3):227-36.
doi: 10.1111/j.1542-474X.2007.00166.x.

Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population

Affiliations

Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population

Fredrik Holmqvist et al. Ann Noninvasive Electrocardiol. 2007 Jul.

Abstract

Background: Patients with hypertrophic cardiomyopathy (HCM) have a high incidence of atrial fibrillation. They also have a longer P-wave duration than healthy controls, indicating conduction alterations. Previous studies have demonstrated orthogonal P-wave morphology alterations in patients with paroxysmal atrial fibrillation. In the present study, the P-wave morphology of patients with HCM was compared with that of matched controls in order to explore the nature of the atrial conduction alterations.

Methods and results: A total of 65 patients (45 men, mean age 49 +/- 15) with HCM were included. The control population (n = 65) was age and gender matched (45 men, mean age 49 +/- 15). Five minutes of 12-lead ECG was recorded. The data were subsequently transformed to orthogonal lead data, and unfiltered signal-averaged P-wave analysis was performed. The P-wave duration was longer in the HCM patients compared to the controls (149 +/- 22 vs 130 +/- 16 ms, P < 0.0001). Examination of the P-wave morphology demonstrated changes in conduction patterns compatible with interatrial conduction block of varying severity in both groups, but a higher degree of interatrial block seen in the HCM population. These changes were most prominent in the Leads Y and Z.

Conclusion: The present study suggests that the longer P-wave duration observed in HCM patients may be explained by a higher prevalence of block in one or more of the interatrial conduction routes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustration of the signal‐averaged P‐wave morphologies. The derived parameters are indicated with dashed lines. Lead X: Xmax location (A) and amplitude (B); Lead Y: Ymax location (C) and amplitude (D); Lead Z: Zmin location (E) and amplitude (F), Zzero location (G), Zmax location (H) and amplitude (I); Spatial magnitude (SM); location of the maximum peak (SM1) (J) and the negative extreme (Nadir) (L). If a second peak was identified (SM2) (K), its location and distance to SM1 were calculated.
Figure 2
Figure 2
Typical examples of Type 1 P‐wave morphology (A), and Type 2 P‐wave morphology (B). Type 3 P‐wave morphology (C) was identified in 11 patients (10 HCM patients and 1 control subject). The pattern is compatible with Bachmann's bundle block. 23 Two patients from the HCM population were excluded from subsequent analysis because of P‐wave morphology noncompatible with sinus rhythm (i.e., predominantly negative Lead Y).
Figure 3
Figure 3
The presence of discrete pathways was further explored using the relative position of the zero crossing in Lead Z (Zzero/Pdur). As seen in the histogram, the parameter is not normally distributed (P < 0.01, Shapiro‐Wilk W test) with two different peaks visible. The two peaks represent Type 2 or 3 and Type 1 morphologies, respectively.

Similar articles

Cited by

References

    1. McKenna WJ, England D, Doi YL, et al Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J 1981;46:168–172. - PMC - PubMed
    1. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997;350:127–133. - PubMed
    1. Olivotto I, Maron BJ, Cecchi F. Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy. Curr Cardiol Rep 2001;3:141–146. - PubMed
    1. Maron BJ, McKenna WJ, Danielson GK, et al American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687–1713. - PubMed
    1. Losi MA, Betocchi S, Aversa M, et al Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 2004;94:895–900. - PubMed

Publication types

MeSH terms